Primary Site >> Colorectal Cancer
Gene >> ALPK1
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Adoptive immunotherapy of malignant disease using LAK cells]. PMID: 3260466 |
Ref: A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma. PMID: 2670212 Ref: [Potent effects of the prostaglandin synthesis inhibitor indomethacin on the cellular immune response in gastrointestinal cancer patients]. PMID: 2778378 |
Ref: The clinical significance of interleukin-2. PMID: 2092277 Ref: Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granular lymphocytes. PMID: 2108487 Ref: Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612. PMID: 2123477 Ref: [Immunotherapy and quality of life]. PMID: 2344201 |
Ref: The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype. PMID: 1706327 Ref: Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cells. PMID: 1787836 Ref: [Effect of UFT by oral administration using a murine hepatic metastasis model]. PMID: 1888182 Ref: [Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases]. PMID: 1944193 |
Ref: CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytes. PMID: 1431336 Ref: [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor]. PMID: 1530292 Ref: Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer. PMID: 1622739 |
Ref: Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. PMID: 8428794 |
Ref: [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients]. PMID: 7720497 Ref: CEA expression of colorectal adenocarcinomas is correlated with their resistance against LAK-cell lysis. PMID: 8168994 |
Ref: [Autologous bone marrow transplantation in intestinal carcinoma]. PMID: 7762252 Ref: Effect of essential fatty acids on natural cytotoxicity in patients with colorectal cancer. PMID: 7781792 Ref: The influence of the local environment on tissue architecture of colorectal carcinoma (CRC) cell aggregates and its consequence for tumour attack by lymphocytes in vitro and in vivo. PMID: 8652264 |
Ref: Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. PMID: 9042431 Ref: Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal-carcinoma cells. PMID: 9212235 Ref: Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients. PMID: 9637344 Ref: IL-2-Activated Killer Cells and Native Cytokines in Treatment of Patients with Advanced Cancer. PMID: 12687071 Ref: Effects of thymic peptides, in vitro, on the impaired immunocytotoxicity of peripheral blood mononuclear cells from tumor patients. PMID: 21533400 Ref: Low molecular thymic peptides improve the deficient immunocytotoxicity of mononuclear cells from tumor patients in vitro. PMID: 21590251 |
Ref: Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. PMID: 9499461 |
Ref: Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. PMID: 11006006 |
Ref: Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers. PMID: 27283888 |